Data at ADA 2026 Highlights Key Findings from Clinical and Real‑World Studies of MannKind’s Afrezza® (Inhaled Insulin) Across Pediatric Care, Pregnancy, and Use with Automated Insulin Delivery (A

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. ABBV
3. META
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to Data at ADA 2026 Highlights Key Findings from Clinical and Real‑World Studies of MannKind’s Afrezza® (Inhaled Insulin) Across Pediatric Care, Pregnancy, and Use with Automated Insulin Delivery (A
Mannkind Corporation (NASDAQ: MNKD) Delayed: 3.93 +0.04 (1.03%)
Previous Close $3.89    52 Week High $2.51 
Open $3.86    52 Week Low $0.41 
Day High $3.94    P/E N/A 
Day Low $3.85    EPS $-0.64 
Volume 2,985,898       

Mannkind Corporation (NASDAQ: MNKD) Delayed: 3.93 +0.04 (1.03%)
Previous Close $3.89    52 Week High $2.51 
Open $3.86    52 Week Low $0.41 
Day High $3.94    P/E N/A 
Day Low $3.85    EPS $-0.64 
Volume 2,985,898